Cargando…

Primary Immune Deficiency: Patients’ Preferences for Replacement Immunoglobulin Therapy

PURPOSE: Immunoglobulin (Ig) replacement therapy is an important life-saving treatment modality for patients with primary antibody immune deficiency disorders (PAD). IVIG and SCIg are suitable alternatives to treat patients with PAD but vary in key ways. Existing evidence on patient preferences for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez, Juan Marcos, Ballow, Mark, Fairchild, Angelyn, Runken, Michael Chris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854788/ https://www.ncbi.nlm.nih.gov/pubmed/35185918 http://dx.doi.org/10.3389/fimmu.2022.827305

Ejemplares similares

Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases
por: Ballow, Mark, et al.
Publicado: (2022)

Fatigue Is Common in Immunoglobulin G Subclass Deficiency and Correlates With Inflammatory Response and Need for Immunoglobulin Replacement Therapy
por: Wågström, Per, et al.
Publicado: (2022)

Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia
por: Compagno, Nicolò, et al.
Publicado: (2014)

What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review
por: Jones, Georgina L., et al.
Publicado: (2018)

Specific Antibody Deficiency: Controversies in Diagnosis and Management
por: Perez, Elena, et al.
Publicado: (2017)

Corrigendum: Specific Antibody Deficiency: Controversies in Diagnosis and Management
por: Perez, Elena, et al.
Publicado: (2018)

Gene Therapies for Primary Immune Deficiencies
por: Kohn, Lisa A., et al.
Publicado: (2021)

Use of Patient Preferences Data Regarding Multiple Risks to Inform Regulatory Decisions
por: Montano-Campos, J. Felipe, et al.
Publicado: (2023)

Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese
por: Kan, Andy Ka Chun, et al.
Publicado: (2022)

Early Enzyme Replacement Therapy Improves Hearing and Immune Defects in Adenosine Deaminase Deficient-Mice
por: Xu, Xiaobai, et al.
Publicado: (2019)

Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency
por: Smits, Bas M., et al.
Publicado: (2020)

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
por: Poto, Remo, et al.
Publicado: (2023)

Differential immunomodulation of T-cells by immunoglobulin replacement therapy in primary and secondary antibody deficiency
por: Dinh, Tri, et al.
Publicado: (2019)

Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments
por: Mohamed, Ateesha F., et al.
Publicado: (2015)

Facilitated Subcutaneous Immunoglobulin Replacement Therapy in Clinical Practice: A Two Center, Long-Term Retrospective Observation in Adults With Primary Immunodeficiencies
por: Wiesik-Szewczyk, Ewa, et al.
Publicado: (2020)

Method for Calculating the Simultaneous Maximum Acceptable Risk Threshold (SMART) from Discrete-Choice Experiment Benefit-Risk Studies
por: Fairchild, Angelyn Otteson, et al.
Publicado: (2022)

Therapeutic Use of Immunoglobulins
por: Stiehm, E. Richard, et al.
Publicado: (2010)

Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies
por: Cinetto, Francesco, et al.
Publicado: (2021)

Subcutaneous immunoglobulin replacement therapy in a patient with 18q deletion syndrome, primary immune deficiency, and type 1 diabetes
por: Hogendorf, Anna, et al.
Publicado: (2021)

Primary Immune Deficiencies – Principles of Care
por: Chapel, Helen, et al.
Publicado: (2014)

Manufacture of Immunoglobulin Products for Patients with Primary Antibody Deficiencies – The Effect of Processing Conditions on Product Safety and Efficacy
por: Farrugia, Albert, et al.
Publicado: (2014)

Analysis of Specific IgG Titers Against Tick-Borne Encephalitis in Patients with Primary Antibody Deficiency Under Immunoglobulin Substitution Therapy: Impact of Plasma Donor Origin
por: Goldacker, Sigune, et al.
Publicado: (2015)

2. Understanding Patient Preferences for Meningococcal Serogroup B Vaccines in the United States
por: Johnson, Reed, et al.
Publicado: (2020)

Principles of and Advances in Immunoglobulin Replacement Therapy for Primary Immunodeficiency
por: Berger, Melvin
Publicado: (2008)

Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
por: Noto, Alessandro, et al.
Publicado: (2023)

Adverse Effects of Immunoglobulin Therapy
por: Guo, Yi, et al.
Publicado: (2018)

Editorial: EBV Infection and Human Primary Immune Deficiencies
por: Cohen, Jeffrey I., et al.
Publicado: (2020)

Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
por: Canessa, Clementina, et al.
Publicado: (2016)

Immunoglobulins, Mucosal Immunity and Vaccination in Teleost Fish
por: Yu, Yongyao, et al.
Publicado: (2020)

Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement
por: Duraisingham, Sai S., et al.
Publicado: (2014)

Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US
por: Guptill, Jeffrey T, et al.
Publicado: (2019)

Case Report: Susceptibility to viral infections and secondary hemophagocytic lymphohistiocytosis responsive to intravenous immunoglobulin as primary manifestations of adenosine deaminase 2 deficiency
por: Drago, Enrico, et al.
Publicado: (2022)

Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells
por: Quinti, Isabella, et al.
Publicado: (2017)

A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance Concept
por: Satgé, Daniel
Publicado: (2018)

Detection of Impaired IgG Antibody Formation Facilitates the Decision on Early Immunoglobulin Replacement in Hypogammaglobulinemic Patients
por: Wolf, Hermann M., et al.
Publicado: (2015)

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey
por: Chan, Alice Y., et al.
Publicado: (2020)

Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
por: Skoda-Smith, Suzanne, et al.
Publicado: (2010)

Immune Modulation for Enzyme Replacement Therapy in A Female Patient With Hunter Syndrome
por: Julien, Daniel C., et al.
Publicado: (2020)

Hypomorphic Mutations in the BCR Signalosome Lead to Selective Immunoglobulin M Deficiency and Impaired B-cell Homeostasis
por: Geier, Christoph B., et al.
Publicado: (2018)

How Does the Public Evaluate Vaccines for Low-Incidence, Severe-Outcome Diseases? A General-Population Choice Experiment
por: Johnson, F. Reed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8opf0ldg8qf4idkb15l6qdgn3c